Download - DVT by shipra omar
![Page 1: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/1.jpg)
THROMBOEM-BOLISM
PRESENTED BY:-SHIPRA OMAR
M.PHARM(CLINICAL PHARMACY) 1st sem
SGRRITS, DEHRADUN
![Page 2: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/2.jpg)
INTRODUCTION:- Thromboembolism/ deep vein thrombosis/ thromboembolic
disorder.
deep vein thrombosis, is the formation of a blood clot (thrombus) within a deep vein.
In 1856, German pathologist Rudolf Virchow postulated the interplay of three processes resulting in venous thrombosis, now known as Virchow's triad a decreased blood flow rate (venous stasis) increased tendency to clot (hypercoagulability) and changes to the blood vessel wall.
![Page 3: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/3.jpg)
CHAPTER 1:- (A) DEFINITION:-
Deep vein thrombosis is the formation of a blood clot in one of the deep veins of the body, usually in the leg, calf thigh etc.
![Page 4: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/4.jpg)
(B):- EPIDEMOLOGY :-o About 1 in 1000 adults per year has DVT inNorth American and European populations.o VTE is rare in children.
o Occurs generally due to deficiencies in protein S, protein C, and antithrombin.
o VTE is common, with an incidence of 25%. PE is now the commonest cause of maternal death, and deep vein thrombosis may result in not only PE but also subsequent morbidity.
o diagnosis is missed generally
![Page 5: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/5.jpg)
Classification of level of VTE risk
Low risk Moderate risk High risk Highest risk
· Minor surgery in patients <40years with no additional riskfactors
· Surgery inpatients 40-60years with noadditional risk factors
· Minor surgeryin patients with additional risk factors
· Surgery inpatients >60years, or age 40-60 with additional risk factors (prior VTE, cancer, molecular hyper-coagulability)
· Surgery inpatients with multiple risk factors (age >40, cancer, prior VTE)
· Hip or knee arthroplasty, hip fracture surgery
· Major trauma, spinal cord injury
![Page 6: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/6.jpg)
(C):- SIGHNS & SYMPTOMS:- Pain
Swelling
Redness or discolouration
Signs and symptoms alone are not sufficiently sensitive to make a diagnosis, but when considered in conjunction with known risk factors can help determine the DVT
Phlegmesia cerulea dolens is a very large and dangerous type of DVT.
It is characterized by an acute and almost total venous occlusion of the entire extremity outflow, including the iliac and femoral veins.
![Page 7: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/7.jpg)
(D) CAUSES :-
Rudolf virchow has identified and given the causes and risk factors that play a kingpin role in the formation of emboli which furthur leads to thrombo embolism/ deep vein thrombosis.
![Page 8: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/8.jpg)
![Page 9: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/9.jpg)
(E) RISK FACTORS :- Cancer Broken leg/ hip Trauma Major surgery Prolonged immobility Inherited Congestive heart failure Unhealthy food habits, smoke, diabetes, hypertension
![Page 10: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/10.jpg)
ACQUIRED:-
Old age Major surgery Inactivity and immobilization Pregnancy Combined oral contraceptives Obesity Polycythemia
polycythemia and polycythemia rubra vera)is a neoplasm in which the bone marrowmakes too many red blood cells. It may also result in the overproduction of white blood cells and platelets.
Most of the health concerns associated with polycythemia vera are caused by the blood being thicker as a result of the increased red blood cells
![Page 11: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/11.jpg)
INHERITED :-
Antithrombin deficiency Protein C deficiency Protein S deficiency Factor V leiden Dysfibrinogenemia Non- O blood type
![Page 12: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/12.jpg)
(F):- PATHOPHYSIOLOGY :- (ACC TO VIRCHOW TRIAD) :-
Stasis
Hypercoagulability
Injury to the vessel wallDamage to the vessel wall can be produced by direct trauma such as major hip or knee surgery, stab wounds or insertion of venous catheters, by direct invasion from cancer cells, or as a consequence of age. Support structures in vessel walls deteriorate with age, leading to weakness and a predisposition to damage from distension.
![Page 13: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/13.jpg)
Injury to the vessel wall
Hypercoagulability
StasisStasis describes the slowing or even cessation of blood flow. This commonly occurs in veins as a result of immobility or paralysis and can lead to concentration and subsequent activation of coagulation factors. Stasis can also cause the vessel walls to become distended, resulting in endothelial damage.
![Page 14: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/14.jpg)
Injury to the vessel wall
Stasis
HypercoagulabilityThe term hypercoagulability means an increased propensity to clot. Hypercoagulability can occur as a result of a genetic defect, stasis, malignancy or hormone changes such as during pregnancy, during administration of oral contraceptives or hormone replacement therapy.
![Page 16: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/16.jpg)
Coagulation system is called cascade consisting of proteins and different factors
DVT occurs due to the abnormalities in antithrombin factor and protein C
Arterial thrombosis is caused by RBCs and platelets that form plaque i.e.: heart attack
Venous thrombosis took place due to fibrin and WBCs
![Page 17: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/17.jpg)
Followed by deposition of fibrin on the endothelial surface which generally prevents clotting
Followed by inflammation
It generally took place in the valves of veins
Due to hypoxemia
Abrupt blood flow and formation of ROS
DVT
![Page 18: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/18.jpg)
OTHER RISK OF DVT: CTEPH It is the important cause of hypertension which leads to pulmonary
embolism
Unresolved thrombus becomes organized and fibrosed leading to obstruction to blood flow
If untreated leads to pulmonary hypertension, left ventricular dysfunction and is fatal to led to death of patient
![Page 19: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/19.jpg)
HISTROY OF CTEPH:-Honey moon period:- exists during which the pulmonary hypertension exists. During this time hypertrophy of right ventricle took place in effort to maintain cardiac output in presence of increased pulmonary resistance.
![Page 20: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/20.jpg)
PATHOLOGY Recurrent PTE in pulmonary artery
Organisation of these thrombi
Organization of thrombus due to slow blood flowIn obstructed pulmonary artery
Increased PVR
Pulmonary hypertension
![Page 21: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/21.jpg)
OTHER RISK OF DVT: B) PULMONARY EMBOLISM When the thrombus or plaque deposits on the endothelial wall, it
restrict the flow of blood into the capillaries
When the plaque becomes hard
A fraction of plaque gets detached and travels with the blood to the heart and then goes to pulmonary veins leads to PE
Furthur leads to hypoxia
Decreased perfusion due to clot in vessel
Increases risk of heart attack and stroke
![Page 22: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/22.jpg)
(G):- DIAGNOSIS:- ABG CXR-
ECG D-Dimer test CT angio Gold standard ECHO Physical examination
Hampton hump
Westermarck sign
![Page 23: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/23.jpg)
i. PHYSICAL EXAMINATION
Decolouration Edema Pitting after pressure applied on calf Pain Ulceration
![Page 24: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/24.jpg)
ii. ABG TEST (ARTERIAL BLOOD GAS)
An arterial blood gas (ABG) is a blood test that is performed using blood from an artery. It involves puncturing an artery with a thin needle and syringe and drawing a small volume of blood. The most common puncture site is the radial artery at the wrist but sometimes the femoral artery & other sites are used. The blood can also be drawn from an arterial catheter.
![Page 25: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/25.jpg)
iii.CXR TEST
Chest X-rayDone to check pulmonary embolism
A. Hamptons humpB. Westermarck sign
![Page 26: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/26.jpg)
A. HAMPTONS HUMP:- Radiological test Opacification of lungs Dome shaped Lung embolism Named after the name of a scientist Otis Hampton (1940)
![Page 27: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/27.jpg)
![Page 28: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/28.jpg)
B. WESTERMARCK SIGN Radiography
Occurs due to obstruct blood flow in the lung
For detection and conformation of PE
![Page 29: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/29.jpg)
iv. ECG:-
SI QIII TIII
Done to check arterial flutter, hypertension, hypoxia
Seen depression or elevation on T wave
1.
2.
3.
![Page 30: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/30.jpg)
v. D-DIMER TEST & ULTRASONO GRAPHY:- A. ELISA B. LATEX & BLOOD AGGLUTION
![Page 31: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/31.jpg)
vi. CT ANGIO:-
Painted blood vessel is filled in heart (either side) Clot in blood vessel can be determineA type of crystal study
![Page 32: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/32.jpg)
vii. GOLD STANDARD:- Accurate test for PE Directly estimate the presence of emboli in the blood vessels Advantageous for d-dimer negetive result Invasive Rarely used May cause genetic risks May cause anaphylaxis Phelbitis (vein inflammation)
![Page 33: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/33.jpg)
viii. ECHO:- By checking tricuspid valve To estimate right ventricular functioning If found
Increased frequency
High work load
Presence of clot any where in lungs
![Page 34: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/34.jpg)
(G):- MANAGEMENT OF THERAPY
![Page 35: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/35.jpg)
(H):- TREATMENT:- Anticoagulants are primarily used. For example:- heparin, caumarins (warfarin) Blood thinners can also be used. Example:- aspirin Thrombolytics used in case of stroke Act by dissolving the clot n preventing clot formation. IVC filters are used
![Page 36: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/36.jpg)
ANTICOAGULANTS:- Heparin prevents extension of the thrombus
Heparin's anticoagulant effect is related directly to its activation of antithrombin III. Antithrombin III, the body's primary anticoagulant, inactivates thrombin and inhibits the activity of activated factor X in the coagulation process.
![Page 37: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/37.jpg)
ANTICOAGULATION FOR FAST RECOVERY:-
Heparin products Heparin IV(unfractionated)
Heparin fractionated
Heparin IV Infused intravenously By drip For unstable patients Immediate use
![Page 38: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/38.jpg)
CONTD.... Dose:- 80 unit/kg bolus 18 unit/kg after 80 units Quick action Disadvantage;-o Turned off if bleeding took placeo May cause heparin induced thrombocytopenia
![Page 39: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/39.jpg)
Heparin fractionated :- Low molecular weight Given sub cutaneously Syn:- enoxiprin (lovanox)
dose;-o 1mg/kg for 12 houro If GFR is <30 then, 1mg/kg for 24 houro No blood level test needed to performo Stable patiento May cause incidence of hits
![Page 40: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/40.jpg)
Superior bioavailability Superior or equivalent safety and efficacy Subcutaneous once- or twice-daily dosing No laboratory monitoring* Less thrombocytopenia Earlier/facilitated
ADVANTAGES OF LOW-MOLECULAR-WEIGHT HEPARIN OVER
STANDARD UNFRACTIONATED HEPARIN
![Page 41: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/41.jpg)
B. WARFARIN:- For slow therapy Vitamin K antagonist Dose:- 5mg/day- 10mg/day Acton 2,7,9,10 factor In case of deficient protein C and S anticoagulants)- vitamin K
dependent Takes 2-3 days to takes speed Medication duration:- 3-6 months to 6-9 month
![Page 42: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/42.jpg)
Disadvantage:- Cause interaction with antibiotics:- Kill bacteria- that produce vitamin K- decreased
vitamin K level- bleeding increased Interact with aspirin n cause internal bleeding
![Page 43: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/43.jpg)
(I):- THROMBOLYTIC THERAPY:-
Advantages prompt resolution of symptoms, prevention of pulmonary embolism, restoration of normal venous circulation, preservation of venous valvular function, and prevention of postphlebitic syndrome
![Page 44: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/44.jpg)
Disadvantage;- Clot propagation, Rethrombosis Subsequent Embolization Heparin therapy and oral anticoagulant therapy always must follow
a course of thrombolysis. Thrombolytic therapy is also not effective once the thrombus is
adherent and begins to organize The uncertainty regarding thrombolytic therapy likely will continue
![Page 45: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/45.jpg)
(J):- SURGERY
when anticoagulant therapy is ineffective unsafe, contraindicated. The major surgical procedures for DVT are clot removal and partial interruption of the
inferior vena cava to prevent pulmonary embolism.
![Page 46: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/46.jpg)
This patient underwent a thrombectomy. The thrombus has been laid over the approximate location in the leg veins where it developed.
![Page 47: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/47.jpg)
(K):-IVC FILTERS:- Indications for insertion of an inferior vena cava filter Pulmonary embolism with contraindication to
anticoagulation Recurrent pulmonary embolism despite adequate
anticoagulation
![Page 48: DVT by shipra omar](https://reader035.vdocuments.net/reader035/viewer/2022081512/58f159a61a28ab25398b4609/html5/thumbnails/48.jpg)
Thank you
Quaries plz???